Gastrointestinalization of moderate heterozygous hyperplasia can be improved by means of medication such as omeprazole, magnesium aluminum carbonate and amoxicillin. However, it is necessary to clarify the specific causes of the disease, and the common causes mainly include chronic gastritis, bile reflux, Helicobacter pylori infection and so on. 1. Chronic gastritis: patients with chronic gastritis, prone to acid reflux belching (hiccups) symptoms, can not be timely and effective treatment, and may affect the normal diet, will lead to gastric mucosa enteric moderate heterotrophic hyperplasia. Need to follow the doctor’s instructions to use omeprazole enteric-coated capsules and other drugs to inhibit gastric acid secretion, but also with the use of domperidone tablets and other drugs to promote gastrointestinal tract power. 2. Bile reflux: due to gastric power disorder, easy to appear bile reflux situation, stimulate the gastric mucosa, the patient will be accompanied by acid belching, loss of appetite, may also increase the risk of gastrointestinal chemotherapy moderate heterozygous hyperplasia. Patients need to follow the doctor’s instructions to use rabeprazole sodium enteric capsules and other drugs to inhibit gastric acid secretion, but also with the use of magnesium aluminum carbonate chewable tablets and other drugs to neutralize the effect of gastric acid. 3. Helicobacter pylori infection: Helicobacter pylori is a pathogenic bacteria hosted in the digestive tract, which can easily bring damage to the gastric mucosa, increase the risk of gastrointestinal chemotherapy moderate isohyperplasia, and may also increase the incidence of gastric cancer. Patients need to follow the doctor’s instructions to use a combination of omeprazole, bismuth potassium citrate, amoxicillin capsules, metronidazole tablets and other drugs for treatment to kill the pathogenic bacteria.